no news is not good news, page-7

They are now quite a way into a couple of these big time collaborations but unfortunately to date there has not been any progression of phylomers into any sort of clinical trial. seems many are realising that it doesnt matter how many big names you sign if you cannot find something they are prepared to run with, and the big payday on this company will only be when a new drug or therapy goes to market using the technology. If we have nitging yet in trials then that is a long way off still. Maybe that explains the dwindling interest with each new collaboration. I cant help but wonder if part of the problem is all these phylomers from far reaching and tough environments are ultimately not derived from human tissue, and so maybe they are not the best match for the required drugs. i recall the company i posted on a while ago that had trials on blood brain barrier crossing therapies were using tissues derived from human breast milk i believe. Anyway looking very sad despite the company spruiking- do or die time now if they dont get some serious income soon.